Search

2021

04 -13

On August 5, the first JD Health "Yunshang Medicine Fair" hosted by JD Health's drug wholesale trading platform "JD Medicine Jingcai" closed. In the three-day online exhibition, more than 300 pharmaceutical companies participated in the exhibition, hundreds of thousands of people in the pharmaceutical industry visited the "cloud exhibition" and watched live broadcasts. Sales of more than 30 exhibitors increased by more than 300% year-on-year.

2018

08 -23

Chongqing Pharmaceutical Research Institute Co., Ltd. has received funding from the Bill & Melinda Gates Foundation for the development of a large-scale semi-synthetic Artemisinin process

2021

04 -13

2019 is an important transformation and key upgrade year for the development of my country's pharmaceutical industry. The pace of industrial reform has accelerated, the pace of market opening has accelerated, and the growth of the industry has slowed down, but the quality of industrial operations has improved. Driven by new environmental pressures such as encouraging competition, centralized procurement, price reduction, rational use of medicines

2021

04 -13

Pancreatic cancer is highly lethal. The fundamental reason for its refractory is that pancreatic cancer cells are wrapped in a dense matrix barrier, which hinders the infiltration of therapeutic drugs and makes it difficult to remove tumor cells. In order to promote the penetration of therapeutic drugs through the matrix barrier,

ABOUT US

CPRI

Chongqing Pharmaceutical Research Institute was founded in 1950 andused to be a leading public institution fully dedicated to pharmaceutical research and development in Southwest China. In 2001, it underwent a historical event that the ownership of CPRI was converted to jointly owned by Shanghai Fosun Pharmaceutical (Group) Co., Ltd and Chongqing Pharmaceutical (Group) Co., Ltd, whereby Chongqing Pharmaceutical Research Institute Co., Ltd was founded (hereinafter referred to as the CPRI). In September 2019, YaoPharma Co., Ltd. took full control of CPRI.

Contact Us

No.565 · NanAnDistrict · ChongQing
Tel:
86-023-62505956
E-mail:cpri@cpri.com.cn

Chongqing Pharmaceutical Research Institute      渝ICP备18002359号       POWERED BY 300.CN